This inventor holds 2 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Hoechst Aktiengesellschaft. Active years: 1998-2000.
Company Filing History:
1 out of 330 
1 out of 6,705 
Years Active: 1998-2000
Title: Gunter Billen: Innovator in Pharmaceutical Chemistry
Introduction
Gunter Billen is a notable inventor based in Niedernhausen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various medical conditions. With a total of 2 patents to his name, his work has the potential to impact the treatment of several disorders.
Latest Patents
Billen's latest patents include innovative compounds such as substituted diaminocarboxylic acids, which are suitable for the production of pharmaceuticals aimed at preventing and treating disorders associated with increased activity of matrix-degrading metalloproteinases. Another significant patent involves alkylxanthine phosphonates and alkylxanthine phosphine oxides, which are designed for the treatment of conditions like muscular atrophy, cachexia, and various inflammatory disorders. These compounds are crucial in addressing issues related to protein loss and systemic inflammation.
Career Highlights
Throughout his career, Gunter Billen has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Deutschland GmbH and Hoechst Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Billen has collaborated with notable colleagues such as Wilfried Schwab and Bernhard Neises. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Gunter Billen's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments and therapies.